中国动脉粥样硬化网 >> 网站地图 >> 第95页:
http://www.sinoas.com/SiteMap/Article002.htm
视网膜小动脉直径与高血压的关系Retinal Arteriolar Diameter Linked to Development of Hyperte
左西孟旦可延长多巴酚丁胺治疗无效心衰患者的生存Levosimendan Extends Survival in Dobutamine-Resistant Heart Failure
心衰治疗中加用缬沙坦可减少房颤的发生Addition of Valsartan to Heart Failure Therapy Curbs Atrial Fibrillation
奈力西肽与心衰的死亡危险密切相关Nesiritide Linked to HF Death Risk
奈西立肽加重了心衰患者的肾功能危险Nesiritide Worsens Kidney Risk in Patients With Heart Failure
半胱氨酸蛋白酶抑制剂C的浓度是老年心衰患者的一项危险因素Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
晚期心衰患者发病率和死亡率的超声心动图预测 β受体阻滞剂生存率评估试验(BEST)Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure The Beta-blocker Evaluation of Survival Trial (BEST)
急性失代偿性心衰院内死亡的预测指标得以确定Predictors of ADHF in-Hospital Death Identified
LVAD可促使心衰过程中β-肾上腺素能反应正常化LVAD Prompts Normalization of Beta-Adrenergic Response in Failing Heart
终末期心衰可进行家庭正性肌力治疗Home-Based Inotropic Therapy Practical for End-Stage Heart Failure
依普利酮对心梗后心衰治疗的费效关系佳Eplerenone Cost-Effective in Post-MI Heart Failure
ACE 抑制剂可改善心衰患者的认知功能ACE Inhibitor Therapy May Boost Cognitive Function in Heart Failure Patients
左西孟旦降低心衰进展中的生物标记物Levosimendan Reduces Heart Failure Progression Biomarkers
舒张期心衰并不全是由心脏问题引起Diastolic HF Not Always Due to Heart Problems
肾移植可改善心衰的结果Kidney Transplantation May Improve Heart Failure
在家进行变力治疗对终末期心衰的治疗是可行的Home-Based Inotropic Therapy Practical for End-Stage Heart Failure
噻唑烷二酮类和二甲双胍可能对心衰患者有帮助Thiazolidinediones and Metformin May Be Helpful in Heart Failure
心率不影响美托洛尔对心衰的益处Heart Rate Does Not Affect Benefit of Metoprolol in Heart Failure
奈必洛尔可降低老年心衰患者的发病率和死亡率Nebivolol Reduces Morbidity and Mortality in Elderly Patients With Heart Failure
大多数ACE抑制剂在心衰患者的治疗中是可互换的ACE Inhibitors Largely Interchangeable in Heart Failure Patients
奈西立肽加重了心衰患者的肾功能危险Nesiritide Worsens Kidney Risk in Patients With Heart Failure
LVAD可促使心衰过程中β-肾上腺素能反应正常化LVAD Prompts Normalization of Beta-Adrenergic Response in Failing Heart
ACE 抑制剂可改善心衰患者的认知功能ACE Inhibitor Therapy May Boost Cognitive Function in Heart Failure Patients
ACC年会:CARE-HF: 心脏再同步治疗预防心衰死亡CARE-HF: CRT Prevents Some HF Deaths
他汀可改善心衰患者的收缩功能Statin Improves Systolic Function in HF
依普利酮对心梗后心衰治疗的费效关系佳Eplerenone Cost-Effective in Post-MI Heart Failure
奈必洛尔可降低老年心衰患者的发病率和死亡率Nebivolol Reduces Morbidity and Mortality in Elderly Patients With Heart Failure
大多数ACE抑制剂在心衰患者的治疗中是可互换的ACE Inhibitors Largely Interchangeable in Heart Failure Patients
治疗糖尿病的药物“与心衰无关”Antidiabetic Drugs Not Linked with HF
美托洛尔控释片/缓释片在合并糖尿病的慢性心力衰竭患者中应用的有效性、安全性和耐受性:来自MERIT-HF试验的经验Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF
他汀治疗可改善老年心衰患者的生存Statin Therapy May Improve Survival in Elderly Heart Failure Patients
噻唑烷二酮类和二甲双胍可能对心衰患者有帮助Thiazolidinediones and Metformin May Be Helpful in Heart Failure
心率不影响美托洛尔对心衰的益处Heart Rate Does Not Affect Benefit of Metoprolol in Heart Failure
导管消融术对“心衰患者发生的房颤有用”Catheter Ablation ‘Useful for AF in HF’
β受体阻滞剂可降低肾病的心衰危险Beta Blockers Reduce HF Risk in Renal Disease
伴有心衰并应用胰岛素治疗的糖尿病患者死亡率飙升Mortality Boosted in Insulin-Using Diabetics With Heart Failure
他汀类药物对心衰患者有益Statins Beneficial in Heart Failure Patients
左西孟旦减轻了多巴酚丁胺难治性重症心衰的症状Levosimendan Alleviates Severe Heart Failure Refractory to Dobutamine
治疗糖尿病的药物“与心衰无关”Antidiabetic Drugs Not Linked With HF
他汀治疗可改善老年心衰患者的生存Statin Therapy May Improve Survival in Elderly Heart Failure Patients
西地那非可改善心衰患者的肺功能Sildenafil Improves Lung Function in Heart Failure Patients
伴有心衰并应用胰岛素治疗的糖尿病患者死亡率飙升Mortality Boosted in Insulin-Using Diabetics With Heart Failure
测定BNP对监测急性心衰有用BNP Measurements Useful in Monitoring Acute Heart Failure
b受体阻滞剂在心衰初始治疗中打败ACE抑制剂Beta Blockers Beat ACE Inhibitors in Initial Heart Failure Therapy
他汀类药物对心衰患者有益Statins Beneficial in Heart Failure Patients
心衰治疗的益处受到怀疑HF Disease Management Benefits in Doubt
“网眼袋”可延缓心衰Mesh bag slows HF
β受体阻滞剂可降低肾病的心衰危险Beta blockers reduce HF risk in renal disease
左西孟旦减轻了多巴酚丁胺难治性重症心衰的症状Levosimendan Alleviates Severe Heart Failure Refractory to Dobutamine
导管消融术对心衰患者发生房颤有用Catheter ablation ’useful for AF in HF’
心衰患者进行大型非心脏手术的结果Outcomes in heart failure patients after major noncardiac surgery
肾功能不全作为心衰女性死亡率的独立预测指标Renal insufficiency as an independent predictor of mortality among women with heart failure
充血性心衰(CHF)和接受心脏移植患者的糖基化终产物水平不同Glycation End Product Levels Differ in CHF Patients and Heart Transplant Recipients
血压治疗药物有助于心衰的治疗Blood Pressure Drug Helps Fight Heart Failure
BNP试验可快速、有效地鉴别诊断充血性心衰BNP Test Quick, Useful for Differential Diagnosis of CHF
血细胞比容可预示慢性心衰的死亡率Hematocrit May Predict Mortality in Chronic Heart Failure
测定BNP对监测急性心衰有用BNP Measurements Useful in Monitoring Acute Heart Failure
β受体阻滞剂在心衰初始治疗中打败ACE抑制剂Beta Blockers Beat ACE Inhibitors in Initial Heart Failure Therapy
[AHA2004] 心衰治疗的益处受到怀疑HF disease management benefits in doubt
[AHA2004] 网眼袋(Mesh bag)延缓心衰’Mesh bag’ slows HF
[AHA2004] COMET: CHF住院治疗后β受体阻滞剂减量或停药与死亡率升高相关COMET: Withdrawal or dose reduction of beta blockers after CHF hospitalization associated with increased mortality
充血性心衰(CHF)和接受心脏移植患者的糖基化终产物水平不同Glycation End Product Levels Differ in CHF Patients and Heart Transplant Recipients
血压治疗药物有助于心衰的治疗Blood Pressure Drug Helps Fight Heart Failure研究说它降低了死亡率及住院率It cuts death and hospitalization rates, study says
血细胞比容可预示慢性心衰的死亡率Hematocrit May Predict Mortality in Chronic Heart Failure
肾功能不全作为心衰女性死亡率的独立预测指标Renal insufficiency as an independent predictor of mortality among women with heart failure
心衰患者进行大型非心脏手术的结果Outcomes in heart failure patients after major noncardiac surgery
BNP试验可快速、有效地鉴别诊断充血性心衰BNP Test Quick, Useful for Differential Diagnosis of CHF
b受体阻滞剂可以安全地用于心衰患者Beta Blockers Safe for Heart-Failure Patients
缬沙坦治疗高血压、心衰或高血压合并心衰患者的每日最佳剂量评估Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both.
噻唑烷二酮类药物与充血性心衰和肺水肿有关Thiazolidinediones Linked to Congestive Heart Failure and Pulmonary Edema
依那普利、坎地沙坦、美托洛尔单用或合用对充血性心衰患者心室重构的影响之比较Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.
依普利酮获得新适应症:包括心肌梗死后心衰Eplerenone’s indications expanded to include post-MI heart failure
Tolvaptan可减轻充血性心力衰竭患者的体液潴留Tolvaptan Reduces Fluid Volume in CHF
住院的心衰病人应该尽早使用β受体阻滞剂New Study Supports Earlier Use of Carvedilol in Hospitalized Patients With Heart Failure, Leading to Improved Drug Utilization
Levosimendan可以明显延长失代偿性心衰患者的生存期Levosimendan Shows Significant Survival Benefit in Decompensated Heart Failure
左西孟旦可延长多巴酚丁胺治疗无效心衰患者的生存Levosimendan Extends Survival in Dobutamine-Resistant Heart Failure
心衰治疗中加用缬沙坦可减少房颤的发生Addition of Valsartan to Heart Failure Therapy Curbs Atrial Fibrillation
奈力西肽与心衰的死亡危险密切相关Nesiritide Linked to HF Death Risk
奈西立肽加重了心衰患者的肾功能危险Nesiritide Worsens Kidney Risk in Patients With Heart Failure
半胱氨酸蛋白酶抑制剂C的浓度是老年心衰患者的一项危险因素Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
晚期心衰患者发病率和死亡率的超声心动图预测 β受体阻滞剂生存率评估试验(BEST)Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure The Beta-blocker Evaluation of Survival Trial (BEST)
急性失代偿性心衰院内死亡的预测指标得以确定Predictors of ADHF in-Hospital Death Identified
LVAD可促使心衰过程中β-肾上腺素能反应正常化LVAD Prompts Normalization of Beta-Adrenergic Response in Failing Heart
终末期心衰可进行家庭正性肌力治疗Home-Based Inotropic Therapy Practical for End-Stage Heart Failure
依普利酮对心梗后心衰治疗的费效关系佳Eplerenone Cost-Effective in Post-MI Heart Failure
ACE 抑制剂可改善心衰患者的认知功能ACE Inhibitor Therapy May Boost Cognitive Function in Heart Failure Patients
左西孟旦降低心衰进展中的生物标记物Levosimendan Reduces Heart Failure Progression Biomarkers
舒张期心衰并不全是由心脏问题引起Diastolic HF Not Always Due to Heart Problems
肾移植可改善心衰的结果Kidney Transplantation May Improve Heart Failure
在家进行变力治疗对终末期心衰的治疗是可行的Home-Based Inotropic Therapy Practical for End-Stage Heart Failure
分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75
76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 [95] 96 97 98 99 100
101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125
126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150
151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
176 177 178 179 180 181 182